ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
67,714.53
-0.02%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. MEI Pharma Inc (MEIP)

  7. MEI Pharma Inc (MEIP) News

MEIP

MEI Pharma (MEIP)

MEI Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MEIP
DateTimeSourceHeadlineSymbolCompany
05/21/20243:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
05/21/202412:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
05/20/20243:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
05/09/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
05/09/20243:02PMBusiness WireMEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
05/09/20243:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
04/11/20247:02AMBusiness WireMEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344NASDAQ:MEIPMEI Pharma Inc
04/11/20247:00AMBusiness WireMEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer PatientsNASDAQ:MEIPMEI Pharma Inc
04/10/20247:00AMBusiness WireMEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:MEIPMEI Pharma Inc
03/26/20247:00AMBusiness WireMEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid LeukemiaNASDAQ:MEIPMEI Pharma Inc
02/28/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MEIPMEI Pharma Inc
02/21/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
02/20/20244:33PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MEIPMEI Pharma Inc
02/13/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
02/13/20244:05PMBusiness WireMEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
01/17/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
01/16/20244:00PMBusiness WireMEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024NASDAQ:MEIPMEI Pharma Inc
01/12/20243:00PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MEIPMEI Pharma Inc
01/12/20243:00PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MEIPMEI Pharma Inc
12/26/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
12/22/20233:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
12/20/20238:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
12/20/20238:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
12/18/20233:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
12/11/20233:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
12/11/202311:00AMBusiness WireMEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023NASDAQ:MEIPMEI Pharma Inc
11/14/20237:59PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
11/09/20233:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
11/09/20233:05PMBusiness WireMEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
11/09/20233:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:MEIP

Your Recent History

NASDAQ
MILN
Global X Millennial Cons...
EU
FR2CIBFS7859
Credit Agricole CIB FCIA...
NASDAQ
NBST
Newbury Street Acquisition
NASDAQ
CHW
Calamos Global Dynamic I...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved